Cargando…

Oncogenic role and drug sensitivity of ETV4 in human tumors: a pan-cancer analysis

BACKGROUND: Increasing evidence supports a relationship between E twenty-six variant transcription factor 4 (ETV4) and several cancers, but no pan-cancer analysis has been reported. METHODS: The present study surveyed the effects of ETV4 on cancer using RNA sequencing data obtained from The Cancer G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Rui, Peng, Yanfang, Gao, Zhe, Qian, Jing, Yang, Kang, Wang, Xinfa, Lu, Wenjing, Zhu, Yongjie, Qiu, Dezhi, Jin, Tong, Wang, Gang, He, Junping, Liu, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185867/ https://www.ncbi.nlm.nih.gov/pubmed/37205199 http://dx.doi.org/10.3389/fonc.2023.1121258

Ejemplares similares

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment
por: Xu, Wen-Xiu, et al.
Publicado: (2020)

Comprehensive Analysis of the Oncogenic, Genomic Alteration, and Immunological Landscape of Cation-Chloride Cotransporters in Pan-Cancer
por: Wang, Jie, et al.
Publicado: (2022)

Pan-Cancer Analyses Reveal Oncogenic Role and Prognostic Value of F-Box Only Protein 22
por: Chen, Sen, et al.
Publicado: (2022)

A Pan-Cancer Analysis of the Oncogenic and Immunogenic Role of m6Am Methyltransferase PCIF1
por: Jin, Ming-Zhu, et al.
Publicado: (2021)

The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors
por: Wu, Fei, et al.
Publicado: (2021)

Pan-cancer analysis and in vitro validation of the oncogenic and prognostic roles of AURKA in human cancers
por: Yang, Chuang, et al.
Publicado: (2023)

A Pan-Cancer Analysis of the Oncogenic Role of Twinfilin Actin Binding Protein 1 in Human Tumors
por: Huo, Gengwei, et al.
Publicado: (2021)

A Pan-Cancer Analysis of the Oncogenic Role of Nuclear Transport Factor 2 in Human Cancers
por: Li, Yu, et al.
Publicado: (2022)

A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer
por: Zhu, Weizhen, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group
por: Qiu, Kun-yin, et al.
Publicado: (2021)

Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer
por: Huang, Renhong, et al.
Publicado: (2022)

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma
por: Yu, Qing-Xiang, et al.
Publicado: (2023)

The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia
por: Rodríguez-Hernández, Guillermo, et al.
Publicado: (2021)

The Impact of ETV6-NTRK3 Oncogenic Gene Fusions on Molecular and Signaling Pathway Alterations
por: Kinnunen, Matias, et al.
Publicado: (2023)

Individualized pathway activity algorithm identifies oncogenic pathways in pan-cancer analysis
por: Ke, Xin, et al.
Publicado: (2022)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

Exploring the oncogenic roles of LINC00857 in pan-cancer
por: Ren, Xiaomin, et al.
Publicado: (2022)

Prognostic Pathways Guide Drug Indications in Pan-Cancers
por: Meng, Fanlin, et al.
Publicado: (2022)

Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy
por: Qian, Liyuan, et al.
Publicado: (2021)

The Potential of panHER Inhibition in Cancer
por: Wang, Xiaochun, et al.
Publicado: (2015)

A Novel IL3-ETV6 Fusion in Chronic Eosinophilic Leukemia Not Otherwise Specified With t(5; 12) (q31; p13): A Case Report and Literature Review
por: Zhao, Cenzhu, et al.
Publicado: (2022)

Bioinformatics-Driven Identification of p62 as A Crucial Oncogene in Liver Cancer
por: Wang, Ling, et al.
Publicado: (2022)

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5
por: Currie, Simon L., et al.
Publicado: (2017)

Functional and embedding feature analysis for pan-cancer classification
por: Lu, Jian, et al.
Publicado: (2022)

The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2 Associated Drug Sensitivity in Oral Carcinoma
por: Yeh, Li-Yin, et al.
Publicado: (2020)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma
por: Zhang, Tong, et al.
Publicado: (2021)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

Leukaemic cells expressing ETV6::FRK are sensitive to dasatinib in vivo
por: Mayumi, Azusa, et al.
Publicado: (2023)

Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis
por: Shen, Yu-ting, et al.
Publicado: (2021)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

Diagnostic Utility of IGF2BP1 and Its Targets as Potential Biomarkers in ETV6-RUNX1 Positive B-Cell Acute Lymphoblastic Leukemia
por: Sharma, Gunjan, et al.
Publicado: (2021)

GAPDH: A common housekeeping gene with an oncogenic role in pan-cancer
por: Wang, Jin, et al.
Publicado: (2023)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Synthetic oleanane triterpenoids suppress MYB oncogene activity and sensitize T-cell acute lymphoblastic leukemia cells to chemotherapy
por: Tejera Nevado, Paloma, et al.
Publicado: (2023)

Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
por: Pellecchia, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2cjlpjhiphgr3hn3m0gdrt40i3